{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:54:49Z","timestamp":1790909689946,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"am","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001453","name":"American Brain Tumor Association","doi-asserted-by":"publisher","award":["# DG2200042"],"award-info":[{"award-number":["# DG2200042"]}],"id":[{"id":"10.13039\/100001453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008222","name":"Ivy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) is a highly aggressive brain tumor for which cell-free DNA (cfDNA) has shown promise as a minimally invasive biomarker, yet the biological processes governing cfDNA release and composition in GBM remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated cfDNA release dynamics, fragmentation patterns, variant allele frequencies (VAF), and copy number profiles under controlled experimental conditions using patient-derived GBM cultures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Longitudinal sampling of conditioned media from monocultures revealed progressive increases in cfDNA yield that correlated more strongly with viable cell numbers than with cell death, suggesting that cfDNA production in these models is not solely driven by apoptosis. In co-culture experiments combining GBM cells with normal human astrocytes, distinct tumor- and astrocyte-specific variants enabled deconvolution of mixed-cell populations, and cfDNA composition shifted over time, consistent with increasing astrocyte death under competitive co-culture conditions. Temozolomide treatment altered cfDNA release dynamics, shifting the dominant source from viable cells to cell-death-associated pathways, accompanied by increased cfDNA yield, nucleosomal fragmentation, and evidence of reduced variant diversity under therapeutic pressure. Tumor-derived cfDNA was also detected and deconvolved from plasma in GBM orthotopic xenograft models, with copy number profiles recapitulating those of the parental tumor cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that cfDNA composition is shaped by tumor proliferation, microenvironmental context, and therapeutic stress, establishing a preclinical foundation for interpreting cfDNA-based liquid biopsy signals in GBM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noag204","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:19:51Z","timestamp":1788236391000},"source":"Crossref","is-referenced-by-count":0,"title":["Cell-free DNA sequencing captures tumor dynamics, microenvironment interactions, and treatment pressures in glioblastoma"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2058-0140","authenticated-orcid":false,"given":"Sharvari","family":"Mankame","sequence":"first","affiliation":[{"name":"Bioinnovation and Genome Sciences Division, Translational Genomics Research Institute , Phoenix, Arizona,","place":["USA"]},{"name":"Department of Molecular and Cellular Biology, School of Life Sciences, Arizona State University , Tempe, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angad S","family":"Beniwal","sequence":"additional","affiliation":[{"name":"Mayo Clinic Alix School of Medicine , Phoenix, Arizona,","place":["USA"]},{"name":"Department of Cancer Biology, Mayo Clinic Arizona , Phoenix, Arizona,","place":["USA"]},{"name":"Department of Neurological Surgery, Mayo Clinic Arizona , Phoenix, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-1294","authenticated-orcid":false,"given":"Matthew","family":"Dufault","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic Arizona , Phoenix, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6692-0200","authenticated-orcid":false,"given":"Hersh","family":"Nanda","sequence":"additional","affiliation":[{"name":"Bioinnovation and Genome Sciences Division, Translational Genomics Research Institute , Phoenix, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4303-6145","authenticated-orcid":false,"given":"Maria","family":"Kyriakidou","sequence":"additional","affiliation":[{"name":"Bioinnovation and Genome Sciences Division, Translational Genomics Research Institute , Phoenix, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2014-9764","authenticated-orcid":false,"given":"Ogechukwu","family":"Mbegbu","sequence":"additional","affiliation":[{"name":"Bioinnovation and Genome Sciences Division, Translational Genomics Research Institute , Phoenix, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-2709","authenticated-orcid":false,"given":"Nanyun","family":"Tang","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute Clinical Genomics and Therapeutics Division, , Phoenix, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhan L","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Mayo Clinic Arizona , Phoenix, Arizona,","place":["USA"]},{"name":"Department of Neurological Surgery, Mayo Clinic Arizona , Phoenix, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-6787","authenticated-orcid":false,"given":"Michael E","family":"Berens","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute Clinical Genomics and Therapeutics Division, , Phoenix, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-4180","authenticated-orcid":false,"given":"Floris P","family":"Barthel","sequence":"additional","affiliation":[{"name":"Bioinnovation and Genome Sciences Division, Translational Genomics Research Institute , Phoenix, Arizona,","place":["USA"]},{"name":"Department of Molecular and Cellular Biology, School of Life Sciences, Arizona State University , Tempe, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026100122371984500_noag204-B1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: primary brain and Central nervous system tumors diagnosed in the United States in 2008-2012","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"2026100122371984500_noag204-B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174279","article-title":"Recurrent glioblastoma: a review of the treatment options","volume":"15","author":"Vaz-Salgado","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026100122371984500_noag204-B3","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMra1706174","article-title":"Application of cell-free DNA analysis to cancer treatment","volume":"379","author":"Corcoran","year":"2018","journal-title":"N Engl J Med"},{"key":"2026100122371984500_noag204-B4","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.1038\/ncomms9760","article-title":"Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer","volume":"6","author":"Murtaza","year":"2015","journal-title":"Nat Commun"},{"key":"2026100122371984500_noag204-B5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1158\/1078-0432.CCR-19-2533","article-title":"Clinical utility of plasma Cell-Free DNA in adult patients with newly diagnosed glioblastoma: a pilot prospective study","volume":"26","author":"Bagley","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2026100122371984500_noag204-B6","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809323","article-title":"Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients","volume":"10","author":"Mouliere","year":"2018","journal-title":"EMBO Mol Med"},{"key":"2026100122371984500_noag204-B7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40478-020-01057-7","article-title":"Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma","volume":"8","author":"Fontanilles","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"2026100122371984500_noag204-B8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-019-0882-3","article-title":"Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid","volume":"565","author":"Miller","year":"2019","journal-title":"Nature"},{"key":"2026100122371984500_noag204-B9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci Transl Med"},{"key":"2026100122371984500_noag204-B10","doi-asserted-by":"publisher","first-page":"103166","DOI":"10.1016\/j.critrevonc.2020.103166","article-title":"The main sources of circulating cell-free DNA: apoptosis, necrosis and active secretion","volume":"157","author":"Hu","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026100122371984500_noag204-B11","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"key":"2026100122371984500_noag204-B12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0009-8981(01)00665-9","article-title":"About the possible origin and mechanism of circulating DNA apoptosis and active DNA release","volume":"313","author":"Stroun","year":"2001","journal-title":"Clin Chim Acta"},{"key":"2026100122371984500_noag204-B13","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s00018-017-2495-z","article-title":"Kinetic analysis, size profiling, and bioenergetic association of DNA released by selected cell lines in vitro","volume":"74","author":"Aucamp","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"2026100122371984500_noag204-B14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbamcr.2015.10.022","article-title":"Characterization of the cell-free DNA released by cultured cancer cells","volume":"1863","author":"Bronkhorst","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2026100122371984500_noag204-B15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-19-0909","article-title":"Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma","volume":"26","author":"Vaubel","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2026100122371984500_noag204-B16","doi-asserted-by":"publisher","first-page":"i172","DOI":"10.1093\/bioinformatics\/bts236","article-title":"Xenome\u2014a tool for classifying reads from xenograft samples","volume":"28","author":"Conway","year":"2012","journal-title":"Bioinformatics"},{"key":"2026100122371984500_noag204-B17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12859-018-2353-5","article-title":"XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data","volume":"19","author":"Kluin","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"2026100122371984500_noag204-B18","doi-asserted-by":"publisher","first-page":"e0327483","DOI":"10.1371\/journal.pone.0327483","article-title":"Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse","volume":"20","author":"Fu","year":"2025","journal-title":"PLoS One"},{"key":"2026100122371984500_noag204-B19","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat Commun"},{"key":"2026100122371984500_noag204-B20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41571-022-00679-1","article-title":"Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges","volume":"19","author":"Noorani","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2026100122371984500_noag204-B21","doi-asserted-by":"publisher","first-page":"1194405","DOI":"10.3389\/fonc.2023.1194405","article-title":"Extrachromosomal DNA (ecDNA) in cancer: mechanisms, functions, and clinical implications","volume":"13","author":"Dong","year":"2023","journal-title":"Front Oncol"},{"key":"2026100122371984500_noag204-B22","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1038\/s41467-019-10493-6","article-title":"Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma","volume":"10","author":"Henrik Heiland","year":"2019","journal-title":"Nat Commun"},{"key":"2026100122371984500_noag204-B23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41698-025-00902-z","article-title":"Benchmarking mouse contamination removing protocols in patient-derived xenografts genomic profiling","volume":"9","author":"Bhandari","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"2026100122371984500_noag204-B24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jmoldx.2011.06.003","article-title":"Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays","volume":"13","author":"Crespo","year":"2011","journal-title":"J Mol Diagn"},{"key":"2026100122371984500_noag204-B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218062","article-title":"Putative origins of Cell-Free DNA in humans: a review of active and passive nucleic acid release mechanisms","volume":"21","author":"Grabuschnig","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026100122371984500_noag204-B26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41419-024-07003-y","article-title":"Extracellular vesicle-associated DNA: ten years since its discovery in human blood","volume":"15","author":"Tsering","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026100122371984500_noag204-B27","doi-asserted-by":"publisher","first-page":"ii33","DOI":"10.1093\/noajnl\/vdac034","article-title":"Tapping into the genome: the role of CSF ctDNA liquid biopsy in glioma","volume":"4","author":"Friedman","year":"2022","journal-title":"Neurooncol Adv"},{"key":"2026100122371984500_noag204-B28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis"},{"key":"2026100122371984500_noag204-B29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41588-018-0105-0","article-title":"Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma","volume":"50","author":"deCarvalho","year":"2018","journal-title":"Nat Genet"},{"key":"2026100122371984500_noag204-B30","doi-asserted-by":"publisher","first-page":"111420","DOI":"10.1016\/j.celrep.2022.111420","article-title":"Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma","volume":"40","author":"Qazi","year":"2022","journal-title":"Cell Rep"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag204\/70885980\/noag204.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag204\/70885980\/noag204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:37:27Z","timestamp":1790908647000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article\/doi\/10.1093\/neuonc\/noag204\/8777189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag204","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"noag204"}}